Zimmer Biomet (ZBH) Holdings announced it has completed the acquisition of Monogram Technologies (MGRM). With the acquisition complete, Monogram shares ceased trading on the National Association of Securities Dealers Automated Quotations prior to the opening of the market on October 7, 2025, and will be delisted.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZBH:
- Zimmer Biomet’s Innovative Hip System Gains Approval in Japan, But Hold Rating Maintained Amid Uncertainty
- Zimmer Biomet’s hip replacement system approved by Japan’s PMDA
- Zimmer Biomet price target raised to $118 from $115 at Stifel
- Target initiated, Nike upgraded: Wall Street’s top analyst calls
- Zimmer Biomet initiated with a Buy at Rothschild & Co Redburn